Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells
被引量:8
Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells
出处
《南京医科大学学报(自然科学版)》
CAS
CSCD
北大核心
2007年第10期1083-1083,共1页
Journal of Nanjing Medical University(Natural Sciences)
关键词
卵巢癌
血管内皮生长因子
基因表达
受体
血管发生
发生机理
cisplatin
ovarian cancer
HIF-1
VEGF
angiogenesis hypoxia-inducible factor-1
targeted inactivation
tumor angiogenesis
factor-receptor
gene
vegf
transcription
progression
induction
pathway
同被引文献19
-
1蒋红元,丰有吉.西罗莫司抑制缺氧诱导因子1α蛋白表达及其对SKOV3裸鼠移植瘤生长的作用[J].中华妇产科杂志,2004,39(7):474-477. 被引量:9
-
2孙学英,孟凡强,姜洪池,乔海泉,李巍.联合反义缺氧诱导因子-1α与B7-1基因治疗肿瘤的实验研究[J].中华肿瘤杂志,2005,27(7):404-407. 被引量:13
-
3汪丛敏,李力,李英惠,吴小华,张金库,宋素格,刘金.VEGF、VEGFR在卵巢癌中的表达及其临床意义[J].肿瘤,2006,26(2):196-198. 被引量:4
-
4段琼文,甄永苏.雷帕霉素相关分子靶点mTOR与新型抗肿瘤药物研制[J].医学研究杂志,2006,35(4):55-58. 被引量:2
-
5胡元晶,曲芃芃.VEGF及其受体在上皮性卵巢癌中的表达及与血管生成的关系[J].中国肿瘤临床,2006,33(23):1346-1349. 被引量:10
-
6王晓珊,吴泰相,侯梅.拓扑替康治疗小细胞肺癌的系统评价[J].中国循证医学杂志,2007,7(3):189-203. 被引量:4
-
7Qian Yang Kun-Liang Guan.Expanding mTOR signaling[J].Cell Research,2007,17(8):666-681. 被引量:52
-
8宋武战,池君,汪静.缺氧诱导因子HIF-lα与恶性肿瘤[J].西南军医,2008,10(1):104-106. 被引量:7
-
9朱玲,郎景和,沈铿,冷金花,刘文淑,许秀英.多药耐药基因表达与卵巢癌耐药关系的研究[J].中华妇产科杂志,1997,32(8):462-466. 被引量:9
-
10丁伟,司维柯,杨景,潘静,孙世俊,李招权.Cyr61和VEGF在肝细胞癌及癌周肝硬化组织中的表达及相关性分析[J].实用肿瘤杂志,2009,24(1):13-17. 被引量:6
引证文献8
-
1林兰,郑秀,余江,江敏,郭彩凤,李素霞.1,25二羟维生素D3联合顺铂对子宫内膜癌HEC-1-A细胞增殖及Skp2/p27表达的影响[J].现代妇产科进展,2010,19(6):423-426. 被引量:2
-
2蒋立辉,吕雯.血管内皮生长因子及其受体2在卵巢上皮癌中的表达[J].实用肿瘤杂志,2010,25(4):422-424. 被引量:4
-
3Wang, Xiaowen Yin, Jinling XU, Jianhong Wang, Hongtao Ma, Guilin.Chemical Stability, Ionic Conductivity of BaCe0.9-xZrxSm0.10O3-α and Its Application to Ammonia Synthesis at Atmospheric Pressure[J].Chinese Journal of Chemistry,2011,29(6):1114-1118. 被引量:4
-
4张媛媛,张广美.缺氧诱导因子-1α(HIF-1α)与卵巢癌多药耐药的关系[J].现代生物医学进展,2012,12(14):2748-2750. 被引量:1
-
5曾庆安,麦卫华,刘星伟.HIF-1α及VEGF在乳腺癌组织中的表达及预后判断[J].现代医药卫生,2013,29(3):324-324.
-
6邓华君,袁雅冬.以HIF-1α为靶点的抗肿瘤药物研究进展[J].国际呼吸杂志,2013,33(14):1104-1109. 被引量:2
-
7张晓莉,闫根全,吴记勇.女性恶性肿瘤对顺铂耐药性分子机制及干预措施研究新进展[J].国际医药卫生导报,2016,22(21):3370-3373. 被引量:1
-
8Hairong wang,Wenwen Zhu,Liangzhu Feng,Qian Chen,Yu Chao,Ziliang Dong,Zhuang Liu.Nanoscale covalent organic polymers as a biodegradable nanomedicine for chemotherapy-enhanced photodynamic therapy of cancer[J].Nano Research,2018,11(6):3244-3257. 被引量:3
二级引证文献17
-
1邱永丰,宋志宇,张文岚.肿瘤相关适配子研究进展[J].实用肿瘤杂志,2011,26(2):204-206.
-
2谢小燕,郑秀.维生素D在子宫内膜癌中的研究进展[J].医学综述,2012,18(4):527-530. 被引量:3
-
3朱剑莉,马桂林,占忠亮.阳极支撑BZCY电解质及GBFN阴极膜在常压合成氨中的性能研究[J].中国稀土学报,2012,30(6):744-749. 被引量:2
-
4李岩,胡冰.恶性腹水的抗血管生成治疗进展[J].安徽医药,2013,17(4):541-543. 被引量:8
-
5金佳佳.卵巢癌术后复发伴恶性腹腔积液1例[J].现代医药卫生,2014,30(12):1919-1920.
-
6沈红,崔进,秦湧,朱祎娜,蔡健康.晚期非小细胞肺癌患者化疗前后血清HIF-1α和VEGF的变化及临床意义[J].现代肿瘤医学,2015,23(6):791-794. 被引量:8
-
7刘淑芝,韩伟,刘先军,崔宝臣.电化学合成氨研究进展[J].化工学报,2017,68(7):2621-2630. 被引量:6
-
8张秀亮,李金华,咸利军,刘刚.HIF-1α、VEGF与晚期非小细胞肺癌化疗疗效及病理参数的相关性分析[J].国际检验医学杂志,2017,38(22):3183-3185. 被引量:6
-
9马驰,林玲,胡敏,袁粒星.肿瘤微环境与卵巢癌耐药的研究进展[J].吉林医学,2018,39(8):1557-1560. 被引量:2
-
10李海燕.铂类抗癌药物作用靶点及耐药机制的研究进展[J].天津药学,2018,30(5):62-66. 被引量:18
-
1Zhi Guo,Hong Ni,Bin Li,Wenge Xing,Fang Liu,Haipeng Yu,Baoguo Li,Xiuying Guo.The Effect of the MDM2-p53 Loop on the Sensitivity of Ovarian Cancer Cells to Cisplatin[J].Chinese Journal of Clinical Oncology,2006,3(2):87-91. 被引量:2
-
2任利容,肖兰,胡建莉,李智敏,王泽华.MDR1 and MDR3 Genes and Drug Resistance to Cisplatin of Ovarian Cancer Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2007,27(6):721-724.
-
3Qi Cao Xin Lu You-Ji Feng.Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells[J].Cell Research,2006,16(7):671-677. 被引量:15
-
4叶大风,谢幸,吕卫国,陈怀增,程蓓.Growth inhibition of interleukin-2 receptor gene-transduced peripheral blood lymphocytes on human ovarian cancer cells[J].Chinese Medical Journal,2001(3):79-83. 被引量:3
-
5卢美松,肖兰,李智敏,胡建莉.The Relationship between p38MAPK and Apoptosis during Paclitaxel Resistance of Ovarian Cancer Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2007,27(6):725-728. 被引量:6
-
6杨琰,王泽华,李敏芳,卢实.Chitosan/pshRNA Plasmid Nanoparticles Targeting MDR1 Gene Reverse Paclitaxel Resistance in Ovarian Cancer Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2009,29(2):239-242. 被引量:1
-
7Qiaoli Zhang,Rami G. Azrak.The effect of methylseleninic acid on paclitaxel efficacy in A2780 ovarian cancer cells[J].Journal of Nanjing Medical University,2009,23(2):111-116.
-
8Huan-Yu Zheng,Hong-Yu Zheng,Yun-Tao Zhou,En-Ling Liu,Jie Li,Yan-Mei Zhang.Changes of TIZ expression in epithelial ovarian cancer cells[J].Asian Pacific Journal of Tropical Medicine,2015,8(2):157-161. 被引量:1
-
9田方,颜春洪,薛红,肖凤君.ADHESION INDUCES MATRIX METALLOPROTEINASE-9 GENE EXPRESSION IN OVARIAN CANCER CELLS[J].Chinese Journal of Cancer Research,2002,14(4):251-253.
-
10熊宙芳,胡沙,王泽华.Cloning of WWOX Gene and Its Growth-inhibiting Effects on Ovarian Cancer Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2010,30(3):365-369. 被引量:2
;